PT1171160E - Metodo e meios para tratar o sindroma pos poliomielite - Google Patents
Metodo e meios para tratar o sindroma pos poliomieliteInfo
- Publication number
- PT1171160E PT1171160E PT00925790T PT00925790T PT1171160E PT 1171160 E PT1171160 E PT 1171160E PT 00925790 T PT00925790 T PT 00925790T PT 00925790 T PT00925790 T PT 00925790T PT 1171160 E PT1171160 E PT 1171160E
- Authority
- PT
- Portugal
- Prior art keywords
- treating
- sindroma
- poliomielite
- pos
- globulin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Color Electrophotography (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/285,125 US6071516A (en) | 1999-04-01 | 1999-04-01 | Treatment of Post-Polio Syndrome with gamma-globulin |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1171160E true PT1171160E (pt) | 2005-09-30 |
Family
ID=23092831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT00925790T PT1171160E (pt) | 1999-04-01 | 2000-03-30 | Metodo e meios para tratar o sindroma pos poliomielite |
Country Status (11)
Country | Link |
---|---|
US (1) | US6071516A (pt) |
EP (1) | EP1171160B1 (pt) |
JP (1) | JP4226789B2 (pt) |
AT (1) | ATE296640T1 (pt) |
AU (1) | AU772499B2 (pt) |
CA (1) | CA2368184C (pt) |
DE (1) | DE60020550T2 (pt) |
ES (1) | ES2243257T3 (pt) |
NZ (1) | NZ514490A (pt) |
PT (1) | PT1171160E (pt) |
WO (1) | WO2000059539A1 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008156418A1 (en) * | 2007-06-19 | 2008-12-24 | Astrazeneca Ab | A method for screening or diagnosis of postpolio syndrome and fibromyalgia |
AU2020378245A1 (en) | 2019-11-04 | 2022-04-07 | Alkahest, Inc. | Blood plasma fractions for use in muscle regeneration |
-
1999
- 1999-04-01 US US09/285,125 patent/US6071516A/en not_active Expired - Lifetime
-
2000
- 2000-03-30 WO PCT/SE2000/000619 patent/WO2000059539A1/en active IP Right Grant
- 2000-03-30 NZ NZ514490A patent/NZ514490A/xx not_active IP Right Cessation
- 2000-03-30 DE DE60020550T patent/DE60020550T2/de not_active Expired - Lifetime
- 2000-03-30 EP EP00925790A patent/EP1171160B1/en not_active Expired - Lifetime
- 2000-03-30 AU AU44425/00A patent/AU772499B2/en not_active Ceased
- 2000-03-30 JP JP2000609102A patent/JP4226789B2/ja not_active Expired - Fee Related
- 2000-03-30 AT AT00925790T patent/ATE296640T1/de not_active IP Right Cessation
- 2000-03-30 PT PT00925790T patent/PT1171160E/pt unknown
- 2000-03-30 ES ES00925790T patent/ES2243257T3/es not_active Expired - Lifetime
- 2000-03-30 CA CA2368184A patent/CA2368184C/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES2243257T3 (es) | 2005-12-01 |
EP1171160A1 (en) | 2002-01-16 |
AU4442500A (en) | 2000-10-23 |
DE60020550T2 (de) | 2006-04-27 |
NZ514490A (en) | 2004-01-30 |
DE60020550D1 (de) | 2005-07-07 |
ATE296640T1 (de) | 2005-06-15 |
JP2002541121A (ja) | 2002-12-03 |
US6071516A (en) | 2000-06-06 |
CA2368184C (en) | 2012-05-08 |
CA2368184A1 (en) | 2000-10-12 |
EP1171160B1 (en) | 2005-06-01 |
AU772499B2 (en) | 2004-04-29 |
JP4226789B2 (ja) | 2009-02-18 |
WO2000059539A1 (en) | 2000-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002100390A3 (en) | Improved method of treating the syndrome of coronary heart disease risk factors in humans | |
UA88270C2 (ru) | Фармацевтический препарат и его применение для профилактики удара, диабета | |
NO20014842D0 (no) | Docetaksel i kombinasjon med rhuMAb HER2 for behandling av kreft | |
IL195723A (en) | Use of p53 inhibitors for the preparation of medicament | |
DK1373215T3 (da) | Gelanamycinderivater egnet til behandling af cancer | |
DE60138547D1 (de) | Topisch anwendbare arzneipräparate und verfahren zur behandlung | |
WO2005058233A3 (en) | Methods for treatment of acute pancreatitis | |
HK1068606A1 (en) | Novel aminobenzoephenones | |
BR0213293A (pt) | Uso de tfpi ou de um análogo de tfpi no tratamento de septicemia | |
SE9603725D0 (sv) | New teatment | |
BR0007452A (pt) | Uso de melagatrano ou de um derivado farmaceuticamente aceitável ou pró-droga do mesmo, método de tratamento de inflamação, e, formulação farmacêutica para uso no tratamento de inflamação | |
DE69935526D1 (de) | Supramolekulare komplexe enthaltende arzneimittel | |
NO20042758L (no) | Fremgangsmate for behandling av en pasient som krever analgesi. | |
SE9902597D0 (sv) | New use | |
PT1171160E (pt) | Metodo e meios para tratar o sindroma pos poliomielite | |
YU39598A (sh) | Upotreba duloksetina i njegova farmaceutska smeša | |
DK0799618T3 (da) | Anvendelse af alpha1-adrenoreceptor-antagonister i fremstillingen af et medikament til forebyggelsen og behandlingen af cancer | |
PT980253E (pt) | Somatostatina e agonistas de somatostatina para tratar a insensibilidade a insulina e a sindrome x | |
EA199800864A1 (ru) | Способ лечения при боли, вызванной мигренью | |
PT1150703E (pt) | Terapia de esclerose multipla com chaperonina 10 e beta-interferao | |
SE0102887D0 (sv) | New formulation | |
MX2022011188A (es) | Derivado biciclico fusionado, metodo de preparacion y uso farmaceutico del mismo. | |
FR2839450B1 (fr) | Preparation medicamenteuse notamment pour le traitement des hernies discales | |
BR0316123A (pt) | Formulação farmacêutica aquosa, uso de uma formulação farmacêutica aquosa, e, método de tratamento de um paciente com necessidade de tratamento antitrombótico | |
BR9708037A (pt) | Método para o tratamento de abuso de substância |